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Background: Pseudomonas aeruginosa is an opportunistic pathogen which has the potential to become extremely
harmful in the nosocomial environment, especially for cystic fibrosis (CF) patients, who are easily affected by
chronic lung infections. For epidemiological purposes, discriminating P.aeruginosa isolates is a critical step, to define
distribution of clones among hospital departments, to predict occurring microevolution events and to correlate
clones to their source. A collection of 182 P. aeruginosa clinical strains isolated within Italian hospitals from patients
with chronic infections, i.e. cystic fibrosis (CF) patients, and with acute infections were genotyped. Molecular typing
was performed with the ArrayTube (AT) multimarker microarray (Alere Technologies GmbH, Jena, Germany), a cost-
effective, time-saving and standardized method, which addresses genes from both the core and accessory P.
aeruginosa genome. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were employed
as reference genotyping techniques to estimate the ArrayTube resolution power.
Results: 41 AT-genotypes were identified within our collection, among which 14 were novel and 27 had been
previously described in publicly available AT-databases. Almost 30% of the genotypes belonged to a main cluster of
clones. 4B9A, EC2A, 3C2A were mostly associated to CF-patients whereas F469, 2C1A, 6C22 to non CF. An
investigation on co-infections events revealed that almost 40% of CF patients were colonized by more than one
genotype, whereas less than 4% were observed in non CF patients. The presence of the exoU gene correlated with
non-CF patients within the intensive care unit (ICU) whereas the pKLC102-like island appeared to be prevalent in
the CF centre. The congruence between the ArrayTube typing and PFGE or MLST was 0.077 and 0.559 (Adjusted
Rand coefficient), respectively.
AT typing of this Italian collection could be easily integrated with the global P. aeruginosa AT-typed population,
uncovering that most AT-genotypes identified (> 80%) belonged to two large clonal clusters, and included 12
among the most abundant clones of the global population.
Conclusions: The ArrayTube (AT) multimarker array represented a robust and portable alternative to reference
techniques for performing P. aeruginosa molecular typing, and allowed us to draw conclusions especially suitable
for epidemiologists on an Italian clinical collection from chronic and acute infections.* Correspondence: ballarini@science.unitn.it; giovanna_scalet@yahoo.it
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Molecular typing is an important tool in epidemiologic
studies of infectious diseases, for identifying identical or
closely related strains, sources of infection, and for
detecting cross-transmissions in the nosocomial envir-
onment. Epidemiological outbreaks of bacterial infec-
tions are usually caused by initial exposure to a single
etiologic agent. Therefore, the bacteria identified in the
outbreak are often genetically identical or clonally
related as a consequence of microevolutions events (usu-
ally point mutations) of an ancestor strain [1]. Molecular
typing represents a tool to elucidate the genetic diversity
underlying important phenotypic features such as host
specificity, pathogenicity, antibiotic resistance and viru-
lence [1]. Through molecular typing it is also possible to
monitor the spread and the genetic diversity of nosoco-
mial pathogens such as Pseudomonas aeruginosa. This
bacterium represents a threat for its antibiotic resistance
and its capability to cause a wide range of infections in
human, including urinary tract, blood, and skin infec-
tions, but predominantly respiratory tract infections.
This opportunistic pathogen plays a particularly detri-
mental role in cystic fibrosis (CF) patients, causing
chronic respiratory infections leading to high infection
rate and morbidity [2]. The genome complexity of P.
aeruginosa is assumed to be the major reason for the
adaptation skills of this bacterium to various environ-
mental niches and its ability to cause a wide range of
infections. Its large genome (5–7 Mb) includes core
genes, necessary for survival, and a wide set of accessory
genes conferring functional peculiarities to individual
strains [3]. Such genomic variability derives from the
extended capability of this species to acquire or discard
genomic segments via horizontal gene transfer and re-
combination [3].
Several comprehensive molecular typing techniques
for discriminating among P. aeruginosa strains have
been developed, based either on DNA banding patterns
(e.g. restriction fragment length polymorphism (RFLP)
and pulsed-field gel electrophoresis (PFGE)), on DNA
sequencing (e.g. multilocus sequence typing (MLST) and
genome sequencing) or on DNA hybridization (DNA
macro- and micro-arrays) [1].
PFGE typing is considered the “gold standard” DNA
banding pattern-based method, being the most discrim-
inative for hospital epidemiologists, who need to monitor
the effectiveness of infection control measures [4]. The
PFGE method, generating genome-wide DNA fingerprints
with rare-cutter restriction enzymes, is also a cost-
effective method. Nevertheless, it is extremely labor-
intensive and lacks comparability between laboratories [1].
Nowadays, a viable PFGE pulsotype database for P. aerugi-
nosa is not available, as a consequence of the unsuccessful
efforts to standardize protocols worldwide.After PFGE, MLST has become one of the most popu-
lar genotyping techniques [5]. The MLST is a
sequencing-based method, which identifies SNPs as well
as genomic rearrangements in six or seven conserved
genes. Its significant advantage over PFGE typing is to
be high-throughput and highly reproducible, allowing re-
liable data comparison to public global databases. How-
ever, to date it is still an expensive method and it bears
the in silico complexity associated to sequencing output.
Overall, both DNA-banding pattern-based and
sequencing-based methods present drawbacks, showing
either low reproducibility (PFGE) or high realization
costs (MLST).
DNA hybridization-based methods have recently be-
come a promising alternative for high-throughput inves-
tigation of genetic markers defining bacterial genetic
diversity and relatedness [1,6]. DNA macro- and micro-
arrays methods represent in fact the optimal comprom-
ise between the cost-effectiveness of DNA banding
pattern-based methods and the reproducibility of
sequencing-based methods.
For P. aeruginosa typing, a species-specific
oligonucleotide-microarray has been developed by
Wiehlmann and collaborators [7]. This microarray is
based on the ArrayTube (AT) platform (Alere-Technolo-
gies GmbH, Jena, Germany) and allows the genotyping
of P. aeruginosa strains using 13 informative single nu-
cleotide polymorphisms (SNPs) at conserved loci, the
fliCa/fliCb multiallelic locus and the presence or absence
of the exoS/exoU marker gene. [7]. These reference
alleles are based on the P. aeruginosa PAO1 chromo-
some and are described to be informative with a fre-
quency of > =15% for the rarer allele in the P.
aeruginosa population [8].
In contrast to PFGE-based fingerprinting, the discrim-
ination between isolates based on PAO1- and non
PAO1-like alleles represent a limit for performing phylo-
genetic analyses since these alleles are based on few core
genome loci subjected to diversifying selection and mu-
tation rate is not fast enough to investigate evolutionary
relationships. Similarly to MLST, which is based on
housekeeping genes with high sequence conservation,
the PAO1-based AT profiles are sufficiently stable over
time to make the AT approach ideal for defining related-
ness of isolates for epidemiologic purposes. In order to
define the relatedness between genotypes, the eBURST
algorithm can be applied [9], which divides bacterial
populations into cluster of clones and potentially identi-
fies the ancestral strain. This clustering algorithm is
commonly applied to MLST data [9], but it is suitable to
any typing method based on defined genetic elements
[7,10,11].
Unlike MLST, which scans only genetic informative
traits of the core genome, the AT multimarker
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accessory genome through a set of 38 genetic markers,
so defining the intra-clonal diversity and epidemiological
gene pattern [7]. Moreover, the AT typing, as the MLST,
produces a robust and informative genotyping identify-
ing isolates to the strain level and allowing easy and reli-
able data comparison between laboratories worldwide
[12]. The ArrayTube has been already employed for mo-
lecular typing of P. aeruginosa populations isolated from
various environments [13–17] and it has been shown to
be adequate even when other typing techniques pro-
duced inconsistent results [18].
This work reports the molecular typing of an Italian P.
aeruginosa clinical collection (n = 182), performed with
the AT microarray, and the investigation on the viru-
lence genes/gene islands correlating to the strain source
(infection type or location). Data from a set of strains
were compared with the PFGE and MLST methods, fo-
cusing on the adequateness for epidemiological studies.
The prevalence of specific virulence genes from the
accessory genome in the identified cluster of clones was
defined. AT data of our local population on independent
isolates (n = 124) were clustered according to their gen-
etic similarity and analyzed together with publicly avail-
able P. aeruginosa worldwide AT datasets.
Results and discussion
Genotyping by ArrayTube and comparison to reference
typing techniques
182 P. aeruginosa isolates were collected from three Ital-
ian hospitals, located in Rovereto, Trento, and Verona.
All strains were typed with the ArrayTube (AT), a DNA-
based multimarker microarray. The AT array design and
array experiments are available in the ArrayExpress data-
base (www.ebi.ac.uk/arrayexpress) under accession num-
bers E_MTAB_1108 and A-MEXP-2179, respectively.
Excluding all isolates with identical AT-profile collected
from individual patients, although from different body
sites, 124 independent-strains could be selected. Besides
AT-typing, PFGE and MLST were performed on up to
105 strains of our collection, for comparison purposes.
The AT-genotypes and virulence markers profiles,
PFGE-clone types and MLST genotypes are provided as
supplementary material (Additional file 1).
Concerning the AT-dataset, the AT-genotype was
derived from the 13 SNPs markers plus the fliCa/b mul-
tiallelic locus and the exoS/exoU markers, as described
by Wielhmann and collaborators [7]. Isolates with iden-
tical AT-genotype (i.e. identical hexadecimal code) and
also identical pattern of AT virulence markers were
defined as AT-clones, since they are genetically indistin-
guishable according to the AT approach. Isolates with
identical AT-genotype but different pattern of virulence
markers were referred to as isolates belonging to thesame AT-clonal complex. Finally, isolates with different
AT-genotypes but related, according to eBURST analysis,
were defined as isolates belonging to the same AT-
cluster of clones [7].
The AT-genotyping analysis revealed that the 182 col-
lected strains belonged to 41 different AT-genotypes.
The relative low genomic variation observed in strain-
specific regions within the core genome was concordant
with the high genetic conservation previously found by
genomic sequencing for P. aeruginosa strains [19]. Each
clonal complex, i.e. group of isolates with identical AT-
genotype, comprised 3.0 +/− 5.1 isolates.
A set of strains of our collection was analyzed also
with two genotyping techniques commonly used in
microbiology, which are renowned as high resolution
reference methods, i.e. pulsed-field gel electrophoresis
(PFGE) and multi-locus sequence typing (MLST) [1].
Comparison with these techniques was performed to
gain insights into differences/similarities between
approaches and to verify results of previous research
groups underlining the feasibility of the AT approach for
epidemic strains [18].
The PFGE/SpeI typing was performed on 105 inde-
pendent strains of our collection, and resolved 77 differ-
ent fingerprints, defined as different PFGE clones or
pulsotypes (Additional file 2), against the 32 AT-
genotypes identified by microarray typing within the
same set of isolates. Only 24.0% PFGE/SpeI clones
appeared to be clonal complexes, according to the
phylogenetic analysis, whereas AT-typing identified 15
multi-isolates AT-genotypes out of 32 (42.9%).
The determined Simpson’s diversity index (DI) was
higher for PFGE than AT (DI = 0.992 for PFGE
(0.989–0.996 95% CI); DI = 0.91 for AT (0.872–0.947
95% CI) and the global congruence between the typing
methods was low (adjusted Rand coefficient = 0.077
(0.012–0.140 95% CI)).
The displayed greater discriminatory power of the
PFGE technique compared to AT-typing was concordant
with published data [18] and it is a consequence of the
different definition of a clone on which these two techni-
ques are based. PFGE/SpeI typing resolves isolates by
their SpeI macrorestriction pattern, thus focusing on
presence or absence of recognition sites for the selected
genome-wide rare-cutter restriction endonuclease
(around 36 SpeI sites on the reference P. aeruginosa
PAO1 genome [20]). Differently, the ArrayTube geno-
typing is based on the knowledge of P. aeruginosa gen-
ome organization, and it recognizes presence or absence
of 15 a priori well-known SNPs or gene markers (13 sin-
gle nucleotide polymorphisms (SNPs) and 2 marker
genes) [7]. Being the AT-markers less numerous than
SpeI restriction sites and based solely on the PAO1-
genome, they do not allow to perform phylogenetic
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logical studies, since they are not affected by the genome
instability exhibited by some epidemic strains, which
bias the discrimination power when routine methods are
used [18]. For example, the isolates with genotype 4B9A,
mostly found in CF patients, were dispersed in 4 differ-
ent PFGE clones (D, MM, QQ and UU) (see Additional
file 3). Another example is represented by genotype 6C22,
comprising isolates from the same hospital (Verona) and
even department (Hematology). According to the PFGE
typing, they belonged to 2 different clones, HH and II
although closely related (see Additional file 1). This ex-
ample shows how the microarray typing, despite being
less discriminative than PFGE provides a genotype def-
inition which is particularly suitable for epidemiological
studies. This finding is striking looking at isolates from
the same patient. For example, 2 isolates from patient
P54, presenting genotype 1BAE and identical virulence
profile, were defined as the same epidemiological clone
according to AT approach, but showed 2 different PFGE
fingerprints.
Besides the evaluation of the discriminatory power of
AT versus PFGE typing, we tested whether there was con-
cordance between clusters of clones defined by those tech-
niques. Out of 4 AT clusters of clones identified, only the
3 small clusters had the at least 50% of the clones defined
as part of the same cluster by both AT and PFGE (see
Additional file 3). The isolates from the main AT cluster
instead (including 66 isolates from 11 AT-genotypes) were
spread over 19 different PFGE pulsotypes.
MLST was also applied to a set of independent isolates
(n = 80). Among them, 46 showed a known sequence
type (ST) profile and were grouped in 16 MLST STs with
1 to 11 strains (see Additional file 1). The remaining 34
isolates were defined as new by the MLST Public Data-
base (pubmlst.org/paeruginosa) (see Additional file 4).
However, these 34 new MLST-profiles included 4 profiles
deriving from a combination of known alleles not
described in the public database, 10 profiles due to the
presence of at least one novel allele, and the remaining
20 profiles with medium-quality sequence within one or
multiple alleles, for which the allele type could not be uni-
vocally determined. Excluding the two isolates with > 2
alleles with medium-quality sequences, overall 48 MLST
STs could be identified among the remaining 78 iso-
lates, the majority of which were single-isolate ST
groups (81.3%). The AT-approach identified within the
same set of isolates a smaller number of AT-genotypes,
precisely 24, more than half of which (54.2%) with mul-
tiple isolates (see Additional file 1).
This data suggested a higher discriminatory power of
MLST in comparison to AT-typing, which could be
explained by the much higher information content of se-
quence data on the 7 MLST-marker genes versuspresence/absence of polymorphisms in single nucleo-
tides within the 13 ArrayTube SNPs-markers. The Simp-
son’s index of diversity (DI), calculated on all 78 isolates,
was indeed higher for MSLT than AT microarray typing
(DI = 0.966 for MLST (0.946–0.987 95% CI); DI = 0.924
for AT (0.894–0.954 95% CI)), indicating a higher dis-
criminatory ability of MLST. However, the difference in
discrimination ability was lower than for PFGE versus
AT. Also, the global congruence between MLST and AT
(adjusted Rand coefficient = 0.559 (95% CI)) was higher
than for PFGE versus AT.
Focusing on the 3 AT-groups with the most MLST-
typed isolates, i.e. F469, 4B9A and EC2A, we observed
that within each of these groups, more than 62% of the
isolates (68.8% for the F469 group, 62.5% for 4B9A and
75.0% for EC2A) had an identical MLST-profile, whereas
the other isolates differed for 1 to 3 MLST-alleles from
the dominant clone of the group. By computing the gen-
etic distances between the MLST DNA sequences of the
three AT-types, we observed that highest genetic dis-
tance was equivalent to 0.286 (isolate VRPS110) within
the F469-group, 0.429 (isolate VRPS97) in the 4B9A-
group and 0.143 (isolate FC17) within the EC2A-group
(see Figure 1).
Looking at the three larger AT-groups, the exclusion
of all isolates with medium-quality allele sequences
increased the number of isolates with identical MLST
ST within each group. In detail, all 11 isolates from the
F469 group had an identical MLST-profile, i.e. ST214,
all 6 isolates from EC2A had MLST ST260 and 5 out of
6 isolates within the 4B9A-group corresponded to a
unique sequence type, i.e. ST390.
We observed that excluding all isolates with one or
more medium-quality allele sequences, the disagreement
between the two techniques further decreased, as shown
by the similarly high Simpson’s index of diversity and
the higher global congruence between methods calcu-
lated on the 53 isolates with good quality allele
sequences (DI = 0.926 for MLST (0.888–0.964 95% CI);
DI = 0.922 for AT (0.886–0.959 95% CI); adjust Rand
coefficient = 0.912 (95% CI)).
Overall, the AT-approach was comparably informative
to MLST for genotype definition and additionally pro-
vided information on the accessory genome. Thus, we
employed the AT multimarker microarray to define
genotype and virulence profile for all strains of our col-
lection, identify potential correlations between strain
source and AT-genotype or virulence gene pattern, and
relate our data to the global AT population.
Correlation between AT-genotype and strain source
The strains were collected from three hospitals and were
isolated from patients affected by one of these two dif-
ferent infection-types: chronic infections (from CF
Figure 1 Genetic distances between MLST DNA sequences within AT-groups. The genetic distance between MLST DNA sequences is shown
for AT-groups F469, 4B9A and EC2A. Each graph represents on the horizontal axis the genetic distance to the dominant MLST-ST within the AT-
group and, on the vertical axis, the absolute frequency of each ST.
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tensive care unit (ICU) or other hospital departments
(OTHER)). To investigate whether strain AT-genotype
correlated with strain source, we grouped the 124-
independent isolates of our collection according to their
AT-type, infection type or hospital location.
Overall, 33 out of 41 AT-genotypes were exclusively
found in either CF or non-CF (ICU, OTHER) and,
among the multi-isolate clones, 11 out of 15 AT-types
showed to be prevalent (with more than 80% isolates
each) in either chronic or acute infections (see Figure 2),
supporting previous evidence of an association of clones
to a particular source [15]. The existence of infection-
type specific clones is still under debate [12,21] and the
reduced size of some of our clonal complexes did not
allow us to draw statistically significant conclusions onFigure 2 Distribution of AT-genotypes among chronic and acute infe
acute (ICU and OTHER) infections. B. Histogram plot of frequency data perc
were calculated from the 124 independent P. aeruginosa isolates of our cothe overall behaviour but rather to gather information
on individual genotypes.
Among the 15 multi-isolates AT-genotypes of our col-
lection 4B9A, EC2A, 3C2A were more frequently (more
than 80% of their isolates) associated to chronic infec-
tions, whereas F469, 2C1A, 6C22 to acute infections (see
Figure 2). Despite the unbalanced distribution of isolates
from chronic and acute infections in our settings de-
pending from the hospital location (Additional file 5),
we assumed that a similar distribution of clones would
be observed in the three hospitals, given the short geo-
graphical distance between their locations. Thus, we
attributed the observed prevalence of specific AT-
genotypes exclusively to the infection type. Also, some
of the individually identified correlations confirmed find-
ings of other research groups [7].ctions. A. Venn’s diagram of the 41 AT-genotypes among chronic and
entages for the 15 multi-isolate AT-genotypes identified. Distributions
llection.
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etic similarity, using the eBURST algorithm on the 14
AT-markers designed for genotyping (13 SNPs and
fliCa/fliCb) [15]. By excluding the exoU and exoS mar-
kers, 3 clones collapsed into others, precisely clones
F468 into F469 and EC28, EC29 into EC2A (see
Figure 3).
Focusing on chronic associated isolates, the 4B9A AT-
genotype belonged to the largest AT clonal complex and
correlated to chronic infections, being 88.9% of its iso-
lates collected from CF patients (see Figure 2), in contra-
diction with other collections in which this AT-genotype
was described within keratitis, environmental and COPD
samples [14,15,17]. As for the 4B9A AT-genotype,
EC2A, known as CHA strain [7], was also mostly asso-
ciated to the CF patient cohort (see Figure 2). The iden-
tified correlation is supported by previous studies and
the mechanism of action of strains with this AT-
genotype on human blood cells has been already eluci-
dated [22]. 3C2A was exclusively CF-associated, but it
has been previously described as a frequent AT-type
both in CF and non-CF patients [7]. Among the multi-
isolate AT-genotypes, only one (i.e. 0C2E) out of 3 novelFigure 3 Cluster of AT-clones identified within the 124 independent i
identified by using the eBURST algorithm performed on 13 SNPs plus the m
genotype the % of isolates associated to CF patients, patients from the integenotypes was identified also in CF patients, although in
50% of the cases only.
An investigation on co-infections events, taking in ac-
count the 124-independent isolates collection, revealed
that almost 40% of our CF patients were colonized by
more than one AT-genotype, among which the most fre-
quent were again 4B9A and EC2A but also the 2C22
AT-types (see Figure 4). Interestingly, isolates typed as
4B9A and EC2A, when present, were always co-
colonizers (i.e. patients P11, P12, P13). According to the
eBURST analysis shown in Figure 3, these two AT-
genotypes showed low SNP-profile similarity and were
classified as unrelated by the eBURST analysis of our
collection being part of different cluster of clones. Look-
ing at the accessory-genome markers, the isolates with
4B9A and EC2A AT-type presented an identical pattern
of virulence genes/gene islands (see Additional file 1).
Among the 5 patients infected by more than one AT-
genotype, only an individual patient (P12) was co-
infected by two strains from the same cluster of clones,
with EC2A and 2C22 AT-genotype. Despite the similar
SNP-pattern characterizing these two strains, they differ
in the set of virulence markers for the presence of thesolates of our P.aeruginosa collection. Cluster of clones were
ultiallelic fliCa/fliCb gene. The colour code indicates for each
nsive care unit (ICU) or other hospital units (OTHERS). .
Figure 4 Patients co-infected by isolates belonging to 2 or more AT-genotypes. Patients with chronic or acute infections infected by
isolates with different AT-genotypes are shown. Above each AT-genotype, the corresponding clonal cluster ID or clonal complex ID is indicated
(see Table S1). The number of independent isolates identified for each genotype is indicated in squares and highlighted by a colour code.
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2 C22). Another patient (P5) may be infected by two
highly similar strains, being typed as EC28 and 2C22.
Excluding the exoS/exoU AT core-genome marker, the
EC28 isolate was in fact genotypically identical to the
EC2A one, thus becoming part of the cluster of clone 1,
together with the co-infecting 2C22 strain.
As for chronic infections, acute infections were also
found to be dominated by specific AT-genotypes. In par-
ticular, F469, the absolute most frequent AT-type within
our collection, was exclusively associated to acute infec-
tion (see Figure 2). F469 isolates were primarily found
(62.5%) in patients from the intensive care unit (ICU),
carrying severe acute infections, and secondly (37.5%) in
patients from the hematology unit (OTHER), affected as
well by acute infections (see Additional file 1). The cor-
relation between F469 and acute infections is well sup-
ported by other AT studies, identifying this AT-genotype
within environmental samples and keratitis patients
[15,17] (see Table 1).
The 2C1A AT-genotype, better known as Midlands 1
[23], was also exclusively identified in acute infection
and predominantly (71.0%) in patients affected by an
acute infection of the respiratory apparatus (see Add-
itional file 1). Our finding is in contrast with previous
data, describing the Midlands 1 as the second most
common clone in CF centres in Great Britain [23]. The
6C22 AT-type was exclusively isolated from blood infec-
tions in Verona, and it has been previously mainly
reported as environmental [7,17]. Besides known AT-
genotypes, 2 novel ones, B46A and 4D92, wereidentified. Multiple isolates belonged to these AT-types
which were exclusively found in patients affected by
acute infections, precisely within the intensive care unit
(ICU) of the hospital located in Verona.
Few co-infection events (less than 4%) could be
observed in patients with acute infections, in compari-
son to those observed in patients affected by chronic
infections (almost 40%) (see Figure 4). Moreover, the co-
infecting strains differed in their AT-type in each patient
and, according to the eBURST analysis of our collection,
only one patient (P64) was co-colonized by two strains
with AT-genotypes belonging to the same cluster of
clones (i.e. F469 and B46A). B46A showed a different
set of virulence genes and gene islands than F469, pre-
cisely for the absence of exoU and the presence of the
PAPI1-island.
Correlation between genes or gene islands of the
accessory genome and strain source
The ArrayTube multimarker microarray allowed not
only discriminating among P. aeruginosa genotypes with
proper resolution for epidemiological investigations, but
also defining a molecular profile of key accessory genes
and gene islands and their correlation to infection type
or department. The prevalence of each accessory gen-
ome marker was determined among AT-genotypes
belonging to the 4 cluster of clones identified by
eBURST analysis in our collection of independent iso-
lates (n = 124) (see Figure 5). The main cluster of clones
within our strain collection (cluster 1) was characterized
by genes and gene islands shared by all AT-genotypes of
Table 1 The Pseudomonas aeruginosa AT-genotypes identified in our study and their presence in publicly accessible
AT-databases
AT genotypes Presence in other databases (reference)






0C2E, 6C22, EC22, EC29, EC2A [7,17]
2C22 [14,17]
0F9E, 4992, 7D9A, E59A [7]
002A, 0BA2, 2C2A, CF92 [17]
0C22, 1E1E, 2812, 2D92, 4C0A, 4D92, 4F82, 681A, 842A, 859A, AE0A, B46A, EC28, F468 none
The AT-genotypes identified in our study were search in other published AT-databases [7,14,15,17]. Genotypes were grouped according to the AT-databases
sharing them.
Ballarini et al. BMC Microbiology 2012, 12:152 Page 8 of 12
http://www.biomedcentral.com/1471-2180/12/152the cluster (e.g. the fpvA gene encoding the pyoverdine
outer membrane transporter), but also by AT-type spe-
cific genomic regions such as the exoU gene, the LES-
specific mutations or the fla-glycosilation island.
A statistical analysis [24] revealed that the presence of
the exoU gene positively correlated (p < 0.01) with theFigure 5 Identification of the prevalent genes/gene islands from the
of clones in our collection. The frequency of each gene/gene island is sh
genotype and highlighted by a colour code. The frequency data and numbICU department, which hosted patients with severe
acute infections. This finding was concordant with the
known function of the protein encoded by the exoU
gene, a potent cytotoxin causing damages in lung tissue,
thus not compatible with chronic infections [25]. On the
contrary, the exoS gene, described as mutually exclusiveaccessory genome for each AT-genotype belonging to a cluster
own within each square as a percentage of isolates within each AT-
er of isolates refers exclusively to independent isolates.
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CF strains (p < 0.01).
Besides the exoU gene, a positive correlation was also
identified between the genes belonging to the pKLC102-
like island, in particular genes encoding for pKL-1, pKL-3,
pKLC adhesion, pKLC fatty acid synthase (all with p
< 0.01), the pKLC conserved hypothetical protein (with
p < 0.05) and the infection-type (CF or non-CF). These
5 genes were prevalent in CF strains, not only in our
strain collection but also in the global population (p
< 0.01, except for pKL-3, with p < 0.05) [7] and COPD
isolates (p < 0.01, except for pKL-1, with p < 0.05, and
the pKLC conserved hypothetical protein, which does
not show a statistically significant correlation) [14]. The
function of most of the genes belonging to this island
has not been deciphered yet, but it is known that the
PAPI-1/pKLC102-like members encode virulence fac-
tors, such as cytotoxins, pili, fimbriae and regulators of
biofilm synthesis and antibiotic resistance [27]. Given
the known functions of this island, the identified posi-
tive correlation to chronic infections was unexpected, as
it has been demonstrated that P. aeruginosa reduces its
acute virulence during the adaptation to the CF lung en-
vironment [28]. Nevertheless, Rakhimova and collabora-
tors [14] showed that the pKL-3 gene was associated to
a prolonged colonization time in a minority of P. aerugi-
nosa strains in COPD patients [14], whose lung
colonization pattern by Pseudomonas strains is compar-
able to the one observed in CF patients.Analysis of the AT-genotypes identified within the
publicly available population studies
An intrinsic feature of the AT technology is to be standar-
dized and therefore to guarantee reliable data comparison
between genotyping studies performed worldwide in dif-
ferent laboratories [7]. In order to gain further information
on the 124-independent strains of our collection, we com-
pared them with a global database, obtained by retrieving
information from 4 publicly available AT-datasets, com-
prising a total of 698 isolates [7,14,15,17]. These datasets
comprised 240 strains of diverse habitat and geographic
origin [7], 134 strains collected from patients affected by
chronic obstructive pulmonary disease [14], 63 strains iso-
lated from keratitis [15], and 381 environmental isolates
from rivers [17].
Our 124-independent strain collection included 27
genotypes previously described [7,14,15,17] and 14
which have never been previously reported (see Table 1).
Among the 27 already described AT-genotypes, it is
interesting to notice that 8 of them (D421, 3C2A, C40A,
2C1A, 239A, 0812, E429 and F429) were shared by all
collections [7,14,15,17] and were all among the 16 most
abundant in the global P. aeruginosa population [7].An eBURST analysis using 15 markers (13 SNPs, the
multiallelic fliCa/fliCb locus and exoS/exoU) was per-
formed to illustrate the similarities between SNP profiles
of our and other collections, typed by the AT method.
As shown in Additional file 6, the eBURST analysis
revealed the presence of 2 main clusters of clones and 3
small ones (with 2–3 genotypes each). Most AT clones
also previously described (25 out of 27) belonged to the
2 large clusters, 12 of which were among the 16 most
abundant clones in the global P. aeruginosa population,
namely D421, F469, 1BAE, 2C1A, 0C2E, 239A, 0812,
C40A, E429, EC29, F429 and 3C2A [7]. All novel AT
clones except one (1E1E) were part of the 2 large clus-
ters or gave rise to a small cluster including a previously
described strain (i.e. 4F8A) (see Additional file 6, clones
enclosed in rectangular frames).
Overall, 84.2% clones of the local population (32
out of 38) were equally divided into the two large
clusters of clones and almost 30% (11 out of 38)
were primary founders, i.e. E469, E429, D421, F429,
C40A, EC2A, 0C2E, 0812, 2C1A, 239A, and 1BAE
(see Additional file 6, underlined clones). Among the
11 primary founders identified within our collection,
5 were known to be abundant clones [7], confirming
their dominant role in the global P. aeruginosa
population.
Conclusions
The ArrayTube multimarker-microarray represented a
reliable and reproducible tool for P. aeruginosa molecu-
lar typing. Genotypic data was readily comparable to
public databases and allowed to draw conclusions on the
correlation between isolates and infection type or de-
partment. A comparison with reference genotyping tech-
niques showed how the AT provides a genotypic profile
which is not biased by genome variations within un-
known or not informative regions, and defines addition-
ally epidemiological features to identifying the causative




The P. aeruginosa strain collection (see Additional file 1)
consisted of 107 isolates from the “Borgo Roma” Hos-
pital (Verona, Italy), 14 from the “Santa Chiara” Hospital
(Trento, Italy) and 61 cystic fibrosis isolates from the
“Santa Maria del Carmine” Hospital (Rovereto, Italy).
Strains were confirmed as Pseudomonas aeruginosa iso-
lates using the biochemical assay API-20NE gallery (Bio-
merieux, Inc., Durham, NC), according to the
manufacturer’s instructions. Results were further con-
firmed by PCR amplification of the ecfX gene, as previ-
ously described [29].
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source and their complete AT-profiles is available in the
ArrayExpress database (www.ebi.ac.uk/arrayexpress)
under accession number E_MTAB_1108.
ArrayTube (AT) microarray platform
Each oligonucleotide-microarray for P. aeruginosa typing
was located at the bottom of the ArrayTube (AT), pur-
chased at Alere Technologies GmbH (Jena, Germany).
The core genome was represented by 13 single-nucleotide
polymorphisms (SNPs), the multiallelic fliCa/b locus
and the exoU/exoS genes, while the accessory genome
was represented by 38 genetic markers [7]. The array
design is provided in the ArrayExpress database (www.
ebi.ac.uk/arrayexpress) [30] under accession number
A-MEXP-2179.
Multimarker microarray typing protocol
DNA labeling and amplification were performed on P.
aeruginosa colony DNA by linear amplification in the
presence of dTTP: biotin-16-dUTP as suggested by
the manufacturer (Alere Technologies GmbH, Jena,
Germany). Hybridization was detected by colorimetry,
using a streptavidin-horseradish peroxidase (HRP) conju-
gate and a HRP substrate, according to the kit instruction
manual. Colorimetric detection and image recording were
performed with an ATR03 reader and the IconoClust-AT
software, respectively. Positive signal intensities were
transformed in a binary code. The binary code corre-
sponding to the core genome was converted to a hexa-
decimal code as previously described [7].
Pulsed-field gel electrophoresis (PFGE)
PFGE was performed on 162 isolates of our collection,
as previously described [8,31]. In detail, chromosomal
DNA was prepared in 2% (wt/vol) low melting point
agarose plugs and digested with SpeI restriction enzyme
at 37°C overnight. Samples were run on 1% (wt/vol)
agarose gel in 0.5X TBE buffer at 14°C on a CHEF DR-
III PFGE system (Bio-Rad, Hertsfordshire, United King-
dom). PFGE run settings were: initial switching time 5 s;
final switching time 45 s; gradient 6 V; run time 21 h.
PFGE band patterns were compared as described previ-
ously [4] and the PFGE clusters were defined according
to the criteria established by Tenover and coworkers
[32]. In detail, isolates with band pattern with >85%
similarity were refer to as genetically related clones.
Multilocus sequence typing (MLST)
A total of 80 P. aeruginosa independent isolates were
typed. MLST was performed as described by Maatallah
and co-workers [33]. Briefly, genomic DNA was isolated
by using the “DNeasy Blood & Tissue kit” (Qiagen,
Valencia, CA, USA) following the manufacturer’sguidelines. DNA amplification of the seven housekeep-
ing genes (acsA, aroE, guaA, mutL, nuoD, ppsA and
trpE) was performed with a MiniOpticon real-time
PCR detection system (Bio-Rad Laboratories, Munich,
Germany) using the QuantiTect SYBR Green PCR mix
(Qiagen, Valencia, CA, USA). Standard primers [34]
were employed as previously described [33]. The speci-
ficity of the amplification products was determined by
a final melting curve analysis. DNA products were
purified and sequenced on both strands by Eurofins
MWG Operon GmbH (Ebersberg, Germany) with pub-
lished primers [33]. Sequences were compared to pub-
licly available MLST databases, accessible on the P.
aeruginosa MLST website (http://pubmlst.org/paerugi-
nosa). Each isolate was assigned a sequence type (ST)
number according to its allelic profile. Genetic distance
between MLST profiles was calculated as defined at
http://pubmlst.org/analysis/.
Evaluation of typing methods
The discriminatory index (DI), which indicates the prob-
ability for two strains, sampled randomly from a popula-
tion, to belong to a different type was calculated as
previously described [35]. In order to quantify the con-
gruence between typing methods the adjusted Rand co-
efficient was calculated, using the algorithm available at
http://comparingpartitions.info. The first coefficient quanti-
fies the global agreement between two methods, while the
second indicates the probability that two strains are coher-
ently classified as the same clone by both methods [35,36].
Identification of AT cluster of clones
The relatedness between the AT-genotypes was inferred
with the eBURST clustering algorithm (http.//eBURST.
mlst.net). The algorithm was applied on 13 SNPs located
on the core genome plus the fliCa/b gene [2]. The
eBURST was also employed for comparison to the global
P. aeruginosa AT-database, derived from 4 previous
studies [7,14,15,17].
Analysis of accessory genome AT-profiles
The distribution of accessory genome markers relative
to strain origin or other features was evaluated using the
Monte Carlo method [24]. Strains isolated from the
same patient with equal profile in the accessory genome
were excluded from the analysis.
Additional files
Additional file 1: Database of the 124 P. aeruginosa independent
isolates within our collection. The database shows the clinical data of
the 124 independent P.aeruginosa isolates and presence/absence of
accessory genome genes/islands based on microarray typing. On the
right, the corresponding AT- and MLST-genotype are provided, as well as
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technique employed. ND = not defined; SC = single clone; SP = single
pulsotype.
Additional file 2: PFGE dendrogram with assignment of genetically
related clones of 162 P. aeruginosa isolates of our strain collection.
The UPGMA dendrogram includes a selection of the 124-independent
isolates analyzed by microarray typing (in square boxes). The red line
represents the 85% similarity value and the square brackets indicate the
different clusters identified according to Tenover criteria [32].
Additional file 3: Correlation between microarray typing and PFGE
typing. Multi-isolates AT-genotypes are listed in the first column. The
distribution of the isolates of each multi-isolate AT-genotype among
PFGE pulsotypes is shown in each lane. The frequency data and number
of isolates refers exclusively to independent isolates.
Additional file 4: MLST single allele and allelic profile data for all
80 typed isolates. The database shows for each isolate typed by MLST
single allele and allelic profile. Medium-quality allele sequences were not
determined (n.d.). Novel allele types and allelic profiles are defined as
NEW. The clonal complex corresponding to each ST was added, when
available. All data were obtained by comparison to the MLST Public
Database (pubmlst.org/paeruginosa).
Additional file 5: Distribution of the 41 AT-genotypes identified
among hospital locations. Venn’s diagram of the AT-genotype
distribution among the three hospital locations: Verona, Rovereto, and
Trento. Distributions were calculated from the 124 independent P.
aeruginosa isolates of our collection.
Additional file 6: Cluster of AT-clones identified including all
available AT-typed P. aeruginosa clinical populations. Cluster of
clones were identified by eBurst analysis of our AT-genotypes together
with 4 published AT-databases [7,14,15,17]. The colour code indicates the
AT-genotypes of our strain collection and for each genotype the% of
isolates associated to chronic or acute infections. Novel clones (not
described in other studies) are highlighted by a rectangular box. Clones
predicted by eBURST as group primary founders are underlined.
Authors’ contributions
AB participated in the design of the study, performed part of the AT assays,
performed MLST experiments, analysed AT and MLST data and drafted the
manuscript. GS participated in the design of the study, performed part of the
PFGE assays, analyzed PFGE data, performed statistical analyses and drafted
the manuscript. MK maintained the strain collection and carried out part of
the PFGE and AT experiments. OJ conceived the study, participated in its
design and coordination and revised the manuscript. NC performed AT-
profile evaluation. LW participated to AT-profile evaluation and
interpretation, and critically contributed to the revision of the manuscript. All
authors read and approved the final manuscript.
Acknowledgments
This work was supported by a PhD grant from the University of Verona and
by the Centre for Integrative Biology (Trento, Italy). We thank Ermanno Baldo
and Michele Schinella (“Santa Maria del Carmine” Hospital, Rovereto, Italy) for
providing the CF isolates and clinical data, Paolo Lanzafame (“Santa Chiara”
Hospital, Trento, Italy) and Roberta Fontana (“GB Rossi” Policlinic, Verona,
Italy) for access to the laboratory equipment and clinical data. We thank Amy
S. Spencer for copyediting and Burkhard Tümmler for fruitful collaboration
and critical revision of the manuscript.
Author details
1Centre for Integrative Biology, University of Trento, Trento, Italy.
2Department of Pathology and Diagnostics, University of Verona, Verona,
Italy. 3Klinik für Pädiatrische Pneumologie, Allergologie und Neonatologie,
Medizinische Hochschule Hannover, Hannover, Germany.
Received: 24 October 2011 Accepted: 10 July 2012
Published: 27 July 2012
References
1. Li W, Raoult D, Fournier P-E: Bacterial strain typing in the genomic era.
FEMS Microbiol Rev 2009, 33(5):892–916.2. Govan JR, Deretic V: Microbial pathogenesis in cystic fibrosis: mucoid
Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996,
60:539–74.
3. Mathee K, Narasimhan G, Valdes C, Qiu X, Matewish JM, Koehrsen M, Rokas
A, Yandava CN, Engels R, Zeng E, Olavarietta R, Doud M, Smith RS,
Montgomery P, White JR, Godfrey PA, Kodira C, Birren B, Galagan JE, Lory S:
Dynamics of Pseudomonas aeruginosa genome evolution. Proc Natl Acad
Sci USA 2008, 105:3100–3105.
4. Johnson JK, Arduino SM, Stine OC, Johnson JA, Harris AD: Multilocus
sequence typing compared to pulsed-field gel electrophoresis for
molecular typing of Pseudomonas aeruginosa. J Clin Microbiol 2007, 45
(11):3707–12.
5. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q,
Zhou J, Zurth K, Caugant DA, Feavers IM, Achtman M, Spratt BG: Multilocus
sequence typing: a portable approach to the identification of clones
within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A
1998, 95(6):3140–3145.
6. Ehricht R, Slickers P, Goellner S, Hotzel H, Sachse K: Optimized DNA
microarray allows detection and genotyping of single PCR-amplifiable
target copies. Mol. Cell. Probes. 2006, 20:60–63.
7. Wiehlmann L, Wagner G, Cramer N, Siebert B, Gudowius P, Morales G,
Kohler T, van Delden C, Weinel C, Slickers P, Tummler B: Population
structure of Pseudomonas aeruginosa. Proc. Nat. Acad. Sci. U. S. A. 2007,
104(19):8101–8106.
8. Morales G, Wiehlmann L, Gudowius P, van Delden C, Tummler B, Martinez
JL, Rojo F: Structure of Pseudomonas aeruginos a populations analyzed
by singlenucleotide polymorphism and pulsed-field gel electrophoresis
genotyping. J Bact 2004, 186:4228–4237.
9. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG: eBURST: inferring
patterns of evolutionary descent among clusters of related bacterial
genotypes from multilocus sequence typing data. J. Bact. 2004,
186:1518–1530.
10. Sheludchenko MS, Huygens F, Hargreaves MH: Highly discriminatory
single-nucleotide polymorphism interrogation of Escherichia coli by use
of allele-specific real-time PCR and eBURST analysis. Appl Environ
Microbiol 2010, 76(13):4337–45.
11. Turner KM, Hanage WP, Fraser C, Connor TR, Spratt BG: Assessing the
reliability of eBURST using simulated populations with known ancestry.
BMC Microbiol 2007, 7:30.
12. Cramer N, Wiehlmann L, Tümmler B: Clonal epidemiology of Pseudomonas
aeruginosa in cystic fibrosis. Int J Med Microbiol. 2010, 300(8):526–33.
13. Mainz JG, Naehrlich L, Schien M, Käding M, Schiller I, Mayr S, Schneider G,
Wiedemann B, Wiehlmann L, Cramer N, Pfister W, Kahl BC, Beck JF, Tümmler
B: Concordant genotype of upper and lower airways P. aeruginosa and S.
aureus isolates in cystic fibrosis. Thorax 2009, 64(6):535–40.
14. Rakhimova E, Wiehlmann L, Brauer AL, Sethi S, Murphy TF, Tümmler B:
Pseudomonas aeruginosa population biology in chronic obstructive
pulmonary disease. J Infect Dis 2009, 200(12):1928–35.
15. Stewart RM, Wiehlmann L, Ashelford KE, Preston SJ, Frimmersdorf E,
Campbell BJ, Neal TJ, Hall N, Tuft S, Kaye SB, Winstanley C: Genetic
characterization indicates that a specific subpopulation of Pseudomonas
aeruginosa is associated with keratitis infections. J Clin Microbiol 2011, 49
(3):993–1003.
16. Tielen P, Narten M, Rosin N, Biegler I, Haddad I, Hogardt M, Neubauer R,
Schobert M, Wiehlmann L, Jahn D: Genotypic and phenotypic
characterization of Pseudomonas aeruginosa isolates from urinary tract
infections. Int J Med Microbiol. 2011, 301(4):282–92.
17. Selezska K, Kazmierczak M, Muesken M, Garbe J, Schobert M, Haeussler S,
Wiehlmann L, Rohde C, Sikorski J: Pseudomonas aeruginosa population
structure revisited under environmental focus: impact of water quality
and phage pressure. Environ Microbiol 2012, doi:10.1111/j.1462-
2920.2012.02719.x.
18. Fothergill JL, White J, Foweraker JE, Walshaw MJ, Ledson MJ,
Mahenthiralingam E, Winstanley C: Impact of Pseudomonas aeruginosa
genomic instability on the application of typing methods for chronic
cystic fibrosis infections. J Clin Microbiol 2010, 48(6):2053–9.
19. Kiewitz C, Tuemmler B: Sequence diversity of Pseudomonas aeruginosa
impact on population structure and genome evolution. J Bacteriol 2000,
182:3125–3135.
20. Roemling U, Grotheus D, Bautsch W, Tuemmler B: A physical genome map
of Pseudomonas aeruginosa PAO. EMBO J 1989, 8(13):4081–4089.
Ballarini et al. BMC Microbiology 2012, 12:152 Page 12 of 12
http://www.biomedcentral.com/1471-2180/12/15221. Pirnay J-P, Bilocq F, Pot B, Cornelis P, Zizi M, Van Eldere J, Deschaght P,
Vaneechoutte M, Jennes S, Pitt T, De Vos D: Pseudomonas aeruginosa
Population Structure Revisited. PLoS One 2009, 4(11):e7740.
22. Dacheux D, Toussaint B, Richard M, Brochier G, Croize J, Attree I:
Pseudomonas aeruginosa Cystic Fibrosis Isolates Induce Rapid, Type III
Secretion-Dependent, but ExoU-Independent. Oncosis of Macrophages
and Polymorphonuclear Neutrophils. Infect Immun 2000, 68(5):2916–2924.
23. Scott FW, Pitt TL: Identification and characterization of transmissible
Pseudomonas aeruginosa strains in cystic fibrosis patients in England and
Wales. J Med Microbiol 2004, 53(7):609–615.
24. Sham PC, Curtis D: Monte Carlo tests for associations between disease
and alleles at highly polymorphic loci. Ann Hum Genet 1995, 59:97–105.
25. Finck-Barbancon V, Goranson J, Zhu L, Sawa T, Wiener-Kronish JP, Fleszig
SM, Wu C, Mende-Mueller L, Frank DW: ExoU expression by Pseudomonas
aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol
Microbiol 1997, 25:547–557.
26. Feltman H, Schulert G, Khan S, Jain M, Peterson L, Hauser AR: Prevalence of
type III secretion genes in clinical and environmental isolates of
Pseudomonas aeruginosa. Microbiol. 2001, 147(10):2659–2669.
27. Harrison EM, Carter ME, Luck S, Ou HY, He X, Deng Z, O'Callaghan C,
Kadioglu A, Rajakumar K: Pathogenicity islands PAPI-1 and PAPI-2
contribute individually and synergistically to the virulence of
Pseudomonas aeruginosa strain PA14. Infect Immun 2010, 78(4):1437–1446.
Epub 2010 Feb 1.
28. Hogardt M, Heesemann J: Adaptation of Pseudomonas aeruginosa during
persistence in the cystic fibrosis lung. Int J Med Microbiol. 2010, 300
(8):557–62.
29. Lavenir R, Jocktane D, Laurent F, Nazaret S, Cournoyer B: Improved
reliability of Pseudomonas aeruginosa PCR detection by the use of the
species-specific ecfx gene target. J Microbiol Methods 2007, 70(1):20–9.
30. Parkinson H, Sarkans U, Kolesnikov N, Abeygunawardena N, Burdett T, Dylag
M, Emam I, Farne A, Hastings E, Holloway E, Kurbatova N, Lukk M, Malone J,
Mani R, Pilicheva E, Rustici G, Sharma A, Williams E, Adamusiak T, Brandizi M,
Sklyar N, Brazma A: ArrayExpress update – an archive of microarray and
high-throughput sequencing-based functional genomics experiments.
Nucl Acids Res 2011, 39(Database issue):D1002–D1004.
31. Ratnaningsih E, Dharmsthiti S, Krishnapillai V, Morgan A, Sinclair M, Holloway
BW: A combined physical and genetic map of Pseudomonas aeruginosa
PAO. J. Gen. Micro. 1990, 136:2351–2357.
32. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH,
Swaminathan B: Interpreting chromosomal DNA Restriction Patterns
Produced by pulsed-field gel electrophoresis: criteria for bacterial strain
typing. Microbiology 1995, 33(9):2233–2239.
33. Maatallah M, Cheriaa J, Backhrouf A, Iversen A, Grundmann H, Do T, Lanotte
P, Mastouri M, Elghmati MS, Rojo F, Mejdi S, Giske CG: Population structure
of Pseudomonas aeruginosa from five mediterranean countries: evidence
for frequent recombination and epidemic occurrence of CC235. PLoS
One 2011, 6:e25617.
34. Curran B, Jonas D, Grundmann H, Pitt T, Dowson CG: Development of a
multilocus sequence typing scheme for the opportunistic pathogen
Pseudomonas aeruginosa. J Clin Microbiol 2004, 42(12):5644–5649.
35. Carriço J, Silva-Costa C, Melo-Cristino J, Pinto FR, de Lencastre H, Almeida JS,
Ramirez M: Illustration of a common framework for relating multiple
typing methods by application to macrolide-resistant Streptococcus
pyogenes. J Clin Microbiol 2006, 44(7):2524–32.
36. van Mansfeld R, Jongerden I, Bootsma M, Buiting A, Bonten M, Willems R:
The Population Genetics of Pseudomonas aeruginosa Isolates from
different patient populations exhibits high-level host specificity. PLoS
One 2010, 5(10):e13482.
doi:10.1186/1471-2180-12-152
Cite this article as: Ballarini et al.: Molecular typing and epidemiological
investigation of clinical populations of Pseudomonas aeruginosa using
an oligonucleotide-microarray. BMC Microbiology 2012 12:152.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
